Showing results (1-10 of 205) with videos related to
Sort By:
Pageof 21
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755N Waters, C Lundgren, L O Hansson, et al.Life Sciences|January 1, 1997
Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implicationsA Carlsson, L O Hansson, N Waters, et al.The British Journal of Psychiatry. Supplement|April 22, 1999
A glutamatergic deficiency model of schizophreniaA Carlsson, L O Hansson, N Waters, et al.Journal of Medicinal Chemistry|August 4, 1995
On the quantitative structure-activity relationships of meta-substituted (S)-phenylpiperidines, a class of preferential dopamine D2 autoreceptor ligands: modeling of dopamine synthesis and release in vivo by means of partial least squares regressionL O Hansson, N Waters, S Holm, et al.European Archives of Psychiatry and Clinical Neuroscience|February 2, 2000
Neurotransmitter interactions in schizophrenia-therapeutic implicationsA Carlsson, N Waters, M L CarlssonBiological Psychiatry|December 1, 1999
Neurotransmitter interactions in schizophrenia--therapeutic implicationsA Carlsson, N Waters, M L CarlssonBrain Research. Brain Research Reviews|March 17, 2000
Network interactions in schizophrenia - therapeutic implicationsA Carlsson, N Waters, S Waters, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)P Martin, N Waters, A Carlsson, et al.Journal of Neural Transmission. General Section|January 1, 1994
Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissueL O Hansson, N Waters, B Winblad, et al.European Journal of Pharmacology|November 22, 1997
MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and racloprideP Martin, N Waters, S Waters, et al.Pageof 21